Table 3.

Effect of race on graft survival after 30 d adjusted for other risk factorsa

CharacteristicsHRCIP2)
Black race1.651.46 to 1.86<0.001
Deceased donor1.130.99 to 1.280.070
Preemptive transplant0.850.73 to 0.980.027
Age
    2 to 5 versus 0 to 11.000.77 to 1.300.990
    6 to 12 versus 0 to 11.250.97 to 1.600.087
    >12 versus 0 to 11.471.13 to 1.900.004
No of days hospitalized in month 11.031.02 to 1.03<0.001
Diagnosis (versus other)
    obstructive uropathy0.890.76 to 1.040.147
    aplasia/dysplasia/hypoplasia0.960.82 to 1.120.580
    FSGS1.271.09 to 1.480.002
    reflux nephropathy1.010.78 to 1.310.939
Delayed graft function1.301.11 to 1.530.002
Day 30 eGFR >801.391.23 to 1.56<0.001
Immunotherapy in first 30 d
    cyclosporine0.830.68 to 1.010.065
    tacrolimus0.760.56 to 1.010.062
    azathioprine1.231.05 to 1.430.010
    mycophenolate mofetil0.910.75 to 1.110.347
Rejection within 30 d1.221.08 to 1.370.002
Male0.830.75 to 0.930.001
>5 previous transfusions1.371.21 to 1.55<0.001
HLA-B match
    1 versus 00.900.79 to 1.020.098
    2 versus 00.730.59 to 0.900.003
  • a CI, confidence interval; HR, hazard ratio.